MBS Envision

MBS Envision, a subsidiary of Patheous Health, is a leading national provider of specialized diagnostic services based in Leawood, Kansas. Founded in 1997 and acquired by Patheous Health in 2020, MBS Envision employs a team of 6 individuals and generates revenue exceeding $10,000. The company specializes in providing modified barium swallow studies, a diagnostic tool used to assess swallowing disorders. MBS Envision serves over 500 facility-based customers, encompassing approximately 70,000 beds, across major metropolitan areas including Chicago, Cleveland, Detroit, Akron, Columbus, Cincinnati, Milwaukee, and Madison. Each MBS Envision medical team comprises a physician, a radiologist, and a speech-language pathologist. This multidisciplinary approach ensures the safe, efficient, and effective delivery of patient care diagnostic services. MBS Envision is committed to the ongoing professional development of its staff, providing training, education, and opportunities to stay abreast of advancements in their specialized fields. For more information about MBS Envision's services, please visit their website at mbsenvision.com.